RFK Jr. on Lowering Drug Prices and Healthcare Reforms

Shifting HHS Focus

• 🎯 HHS is changing its trajectory from serving mercantile interests to prioritizing public health.
• 💡 This involves moving away from the influence of the medical industrial complex and big pharmaceutical companies.

Hormone Replacement Therapy Reform

• 🚺 The administration has removed the 20-year-old black box warnings on hormone replacement therapy.
• 📈 Science indicates HRT diminishes risks of fatal heart attacks, cardiac disease, Alzheimer's, and bone fractures, while improving appetite, sleep, energy, and happiness.
• ✅ This remedy will now be available to millions of women previously deprived of it due to scientific malpractice.

Drug Price Negotiations and International Agreements

• 🤝 Agreements have been made with the five biggest pharmaceutical companies, with 12 more in the pipeline.
• 📉 The goal is to ensure that by the end of this administration, the U.S. will have the lowest drug prices of any developed nation for 95% of drugs.
• ⚖️ A bargain with Great Britain was made to raise their drug prices in conformance with U.S. lowering theirs, to counterbalance and protect the ecosystem of innovation.

Prior Authorization and Healthcare Records

• 🏥 A major innovation is the elimination of prior authorization for most procedures, agreed upon by major insurance companies representing 280 million Americans, effective January 2026.
• 💻 The tech industry has agreed to remove blockages preventing individuals from accessing their own healthcare records.
• 📱 Americans will have their healthcare records available on their cell phones, facilitating immediate access to critical information like blood type and allergies.

Deregulation and Savings

• 🚫 The nursing home rule, which overburdened rural areas and Indian reservations, has been revoked.
• 💰 This deregulation is expected to result in $25 billion in savings and prevent the destruction of the nursing home industry in affected communities.